563.81MMarket Cap-11027P/E (TTM)
4.110High3.935Low681.32KVolume4.000Open4.060Pre Close2.74MTurnover0.84%Turnover RatioLossP/E (Static)138.19MShares5.70052wk High4.63P/B329.40MFloat Cap2.60052wk Low--Dividend TTM80.74MShs Float9414.996Historical High--Div YieldTTM4.31%Amplitude0.690Historical Low4.024Avg Price1Lot Size
Savara Stock Forum
NEWS
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented significant data at the American Thoracic Society (ATS) 2024 International Conference. The event, taking place from May 17-22, 2024, in San Diego, CA, featured two important posters.
Poster Board 701, sponsored by Sa...
key indicator for MORE uptrend $3.35
confirmation uptrend - $3.71
mini breakout - $4.24
full breakout - $4.77
stop loss & support - $2.46 $Savara(SVRA.US)$
No comment yet